About our research:

Oslo Myeloma Center is the largest center for clinical myeloma research in the Nordics. 

Since 2015, 790 patients have been enrolled in 53 clinical studies in patients with smoldering multiple myeloma and multiple myeloma including newly diagnosed and relapsed/refractory patients in phase 1, 2, 3 and 4 studies.

Year Patient Number
2015 83
2016 67
2017 84
2018 98
2019 120
2020 83
2021 82
2022 105
2023 (Until September 2023) 114

Number of patients included in the different phases so far (by Sep 2023):
Phase 1 - 85 patients
Phase 2 - 290 patients
Phase 3 - 341 patients
Phase 4 - 72 patients

We collaborate with basal and translational research groups, especially with the KG Jebsen center for B cell malignancies at our hospital. In addition, we have a myeloma registry with both prospective and retrospective data.

 
Page visits: 6475